How much funding has Enveda Biosciences raised?

Enveda Biosciences has raised $740.0M in total funding, most recently a Series D round.

Who are Enveda Biosciences's investors?

Enveda Biosciences's investors include Fpv Ventures, Deerfield Management, Premji Invest, Lingotto, Sanofi Ventures, Dimension Capital.

When was Enveda Biosciences founded?

Enveda Biosciences was founded in 2019.

Where is Enveda Biosciences headquartered?

Enveda Biosciences is headquartered in Boulder, Colorado, United States.

What industry is Enveda Biosciences in?

Enveda Biosciences operates in Artificial Intelligence, Biotech, Drug Discovery.

How many employees does Enveda Biosciences have?

Enveda Biosciences has 201-500 employees.

Enveda Biosciences

Learning from life.

Boulder, United States · Founded 2019 · $740.0M raised

Artificial Intelligence

Biotech

Drug Discovery

Headquarters: Boulder, Colorado
Employees: 201–500
Founded: 2019
Business Model: B2B

Website: enveda.com
Total Funding: $740.0M
Last Round: $150.0M Series DSep 2025
Rounds: 6

About

Enveda is a biotechnology company using AI to map natural chemical diversity and accelerate drug discovery. Its platform reads and translates nature's hidden chemistry at scale, giving drug hunters access to 99.9% of the natural world's molecules for the first time. Enveda has built a pipeline of 10+ development candidates targeting immune and metabolic diseases and discovers new medicines 4x faster than the industry average.

Summary

Enveda Biosciences is an Artificial Intelligence company based in Boulder, United States, founded in 2019. It has raised $740.0M in total across 6 rounds, most recently a $150.0M Series D round in Sep 2025. Investors include Fpv Ventures, Deerfield Management and Premji Invest.

LinkedIn X (Twitter)